Skip to main content
Top
Published in: International Urology and Nephrology 10/2016

01-10-2016 | Nephrology - Original Paper

Lowering dialysate sodium improves systemic oxidative stress in maintenance hemodialysis patients

Authors: Beyza Macunluoglu, Hasan Ali Gumrukcuoglu, Aydin Atakan, Halit Demir, Hamit Hakan Alp, Aytac Akyol, Serkan Akdag, Ahmet Yavuz, Zehra Eren, Sıddık Keskin, Elif Ari

Published in: International Urology and Nephrology | Issue 10/2016

Login to get access

Abstract

Purpose

The purpose of the current prospective study was to evaluate the effects of low sodium dialysate on oxidative stress parameters, blood pressure (BP) and endothelial dysfunction in maintenance hemodialysis (HD) patients.

Methods

After baseline measurements were taken, the dialysate sodium concentration was reduced from 140 to 137 mEq/L. Oxidative stress parameters and flow-mediated dilatation (FMD %) were measured before and after 6 months of HD with low sodium dialysate. Interdialytic weight gain (IDWG) and pre- and post-dialysis BP were monitored during the study.

Results

A total of 52 patients were enrolled and 41 patients completed the study. There was a significant reduction in systolic blood pressure at the end of the study [130.00 (90.00–190.00) vs. 120.00 (90.00–150.00), p < 0.001]. Similarly, there were significant improvements in IDWG [2670.00 (1670.00–4300.00) vs. 1986.00 (1099.00–3998.00), p < 0.001] and FMD % [7.26 (4.55–8.56) vs. 9.56 (6.55–12.05), p < 0.001]. Serum MDA levels (p < 0.001) were significantly decreased; serum SOD (p < 0.001) and GPx (p < 0.001) activities were significantly increased after low sodium HD compared to standard sodium HD.

Conclusion

Our data seem to suggest a potential role of 137 mEq/L sodium dialysate for improving hemodynamic status, endothelial function and reducing oxidative stress than 140 mEq/L sodium dialysate in maintenance HD patients.
Literature
1.
go back to reference Ma KW, Greene EL, Raij L (1992) Cardiovascular risk factors in chronic renal failure and hemodialysis populations. Am J Kidney Dis 19(6):505–513CrossRefPubMed Ma KW, Greene EL, Raij L (1992) Cardiovascular risk factors in chronic renal failure and hemodialysis populations. Am J Kidney Dis 19(6):505–513CrossRefPubMed
2.
go back to reference Dursun B, Dursun E, Suleymanlar G et al (2008) Carotid artery intima-media thickness correlates with oxidative stress in chronic haemodialysis patients with accelerated atherosclerosis. Nephrol Dial Transplant 23(5):1697–1703CrossRefPubMed Dursun B, Dursun E, Suleymanlar G et al (2008) Carotid artery intima-media thickness correlates with oxidative stress in chronic haemodialysis patients with accelerated atherosclerosis. Nephrol Dial Transplant 23(5):1697–1703CrossRefPubMed
3.
go back to reference Menon V, Gul A, Sarnak MJ (2005) Cardiovascular risk factors in chronic kidney disease. Kidney Int 68(4):1413–1418CrossRefPubMed Menon V, Gul A, Sarnak MJ (2005) Cardiovascular risk factors in chronic kidney disease. Kidney Int 68(4):1413–1418CrossRefPubMed
4.
go back to reference Zoccali C, Mallamaci F, Tripepi G (2003) Traditional and emerging cardiovascular risk factors in end-stage renal disease. Kidney Int Suppl 85:105–110CrossRef Zoccali C, Mallamaci F, Tripepi G (2003) Traditional and emerging cardiovascular risk factors in end-stage renal disease. Kidney Int Suppl 85:105–110CrossRef
5.
go back to reference Vaziri ND (2004) Oxidative stress in uremia: nature, mechanisms, and potential consequences. Semin Nephrol 24(5):469–473CrossRefPubMed Vaziri ND (2004) Oxidative stress in uremia: nature, mechanisms, and potential consequences. Semin Nephrol 24(5):469–473CrossRefPubMed
6.
go back to reference Ward RA, McLeish KR (2003) Oxidant stress in hemodialysis patients: What are the determining factors? Artif Organs 27(3):230–236CrossRefPubMed Ward RA, McLeish KR (2003) Oxidant stress in hemodialysis patients: What are the determining factors? Artif Organs 27(3):230–236CrossRefPubMed
7.
go back to reference Bossola M, Tazza L (2015) Wishful thinking: the suprisingly sparse evidence for a relationship between oxidative stress and cardiovascular disease in hemodialysis patients. Semin Dial 28(3):224–230CrossRefPubMed Bossola M, Tazza L (2015) Wishful thinking: the suprisingly sparse evidence for a relationship between oxidative stress and cardiovascular disease in hemodialysis patients. Semin Dial 28(3):224–230CrossRefPubMed
8.
go back to reference Morris ST, McMurray JJ, Rodger RS, Jardine AG (2000) Impaired endothelium-dependent vasodilatation in uraemia. Nephrol Dial Transplant 15(8):1194–1200CrossRefPubMed Morris ST, McMurray JJ, Rodger RS, Jardine AG (2000) Impaired endothelium-dependent vasodilatation in uraemia. Nephrol Dial Transplant 15(8):1194–1200CrossRefPubMed
9.
go back to reference Morris ST, McMurray JJ, Spiers A, Jardine AG (2001) Impaired endothelial function in isolated human uremic resistance arteries. Kidney Int 60(3):1077–1082CrossRefPubMed Morris ST, McMurray JJ, Spiers A, Jardine AG (2001) Impaired endothelial function in isolated human uremic resistance arteries. Kidney Int 60(3):1077–1082CrossRefPubMed
10.
go back to reference Kari JA, Donald AE, Vallance DT et al (1997) Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int 52(2):468–472CrossRefPubMed Kari JA, Donald AE, Vallance DT et al (1997) Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int 52(2):468–472CrossRefPubMed
11.
go back to reference Dishy V, Sofowora GG, Imamura H et al (2003) Nitric oxide production decreases after salt loading but is not related to blood pressure changes or nitric oxide-mediated vascular responses. J Hypertens 21(1):153–157CrossRefPubMed Dishy V, Sofowora GG, Imamura H et al (2003) Nitric oxide production decreases after salt loading but is not related to blood pressure changes or nitric oxide-mediated vascular responses. J Hypertens 21(1):153–157CrossRefPubMed
12.
go back to reference Matrougui K, Schiavi P, Guez D, Henrion D (1998) High sodium intake decreases pressure-induced (myogenic) tone and flow-induced dilation in resistance arteries from hypertensive rats. Hypertension 32(1):176–179CrossRefPubMed Matrougui K, Schiavi P, Guez D, Henrion D (1998) High sodium intake decreases pressure-induced (myogenic) tone and flow-induced dilation in resistance arteries from hypertensive rats. Hypertension 32(1):176–179CrossRefPubMed
13.
go back to reference Van Stone JC, Bauer J, Carey J (1982) The effect of dialysate sodium concentration on body fluid compartment volume, plasma renin activity and plasma aldosterone concentration in chronic hemodialysis patients. Am J Kidney Dis 2(1):58–64CrossRefPubMed Van Stone JC, Bauer J, Carey J (1982) The effect of dialysate sodium concentration on body fluid compartment volume, plasma renin activity and plasma aldosterone concentration in chronic hemodialysis patients. Am J Kidney Dis 2(1):58–64CrossRefPubMed
14.
go back to reference Gumrukcuoglu HA, Ari E, Akyol A et al (2012) Effects of lowering dialysate sodium on carotid artery atherosclerosis and endothelial dysfunction in maintenance hemodialysis patients. Int Urol Nephrol 44(6):1833–1839CrossRefPubMed Gumrukcuoglu HA, Ari E, Akyol A et al (2012) Effects of lowering dialysate sodium on carotid artery atherosclerosis and endothelial dysfunction in maintenance hemodialysis patients. Int Urol Nephrol 44(6):1833–1839CrossRefPubMed
15.
go back to reference Kaya Y, Ari E, Demir H et al (2012) Accelerated atherosclerosis in haemodialysis patients; correlation of endothelial function with oxidative DNA damage. Nephrol Dial Transplant 27(3):1164–1169CrossRefPubMed Kaya Y, Ari E, Demir H et al (2012) Accelerated atherosclerosis in haemodialysis patients; correlation of endothelial function with oxidative DNA damage. Nephrol Dial Transplant 27(3):1164–1169CrossRefPubMed
16.
go back to reference Kutlugün AA, Erdem Y, Okutucu S et al (2011) Effects of lowering dialysate sodium on flow-mediated dilatation in patients with chronic kidney disease. Nephrol Dial Transplant 26(11):3678–3682CrossRef Kutlugün AA, Erdem Y, Okutucu S et al (2011) Effects of lowering dialysate sodium on flow-mediated dilatation in patients with chronic kidney disease. Nephrol Dial Transplant 26(11):3678–3682CrossRef
17.
go back to reference Khoschsorur GA, Winklhofer-Roob BM, Rabl H et al (2000) Evaluation of a sensitive HPLC method for determination of malondialdehyde and application of the method to different biological materials. Chromotographia 52:181–184CrossRef Khoschsorur GA, Winklhofer-Roob BM, Rabl H et al (2000) Evaluation of a sensitive HPLC method for determination of malondialdehyde and application of the method to different biological materials. Chromotographia 52:181–184CrossRef
18.
go back to reference Paglia DE, Valentine WN (1967) Studies on quantitative and qualitive characterization of erythrocyte glutathine peroxidase. J Lab Clin Med 70:158–169PubMed Paglia DE, Valentine WN (1967) Studies on quantitative and qualitive characterization of erythrocyte glutathine peroxidase. J Lab Clin Med 70:158–169PubMed
19.
go back to reference Corretti MC, Anderson TJ, Benjamin EJ et al (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39(2):257–265CrossRefPubMed Corretti MC, Anderson TJ, Benjamin EJ et al (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39(2):257–265CrossRefPubMed
20.
go back to reference Celermajer DS, Sorensen KE, Gooch VM et al (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340(8828):1111–1115CrossRefPubMed Celermajer DS, Sorensen KE, Gooch VM et al (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340(8828):1111–1115CrossRefPubMed
21.
go back to reference Kocak H, Gumuslu S, Sahin E et al (2009) Advanced oxidative protein products are independently associated with endothelial function in peritoneal dialysis patients. Nephrology (Carlton) 14(3):273–280CrossRef Kocak H, Gumuslu S, Sahin E et al (2009) Advanced oxidative protein products are independently associated with endothelial function in peritoneal dialysis patients. Nephrology (Carlton) 14(3):273–280CrossRef
22.
go back to reference Lykkesfeldt J (2007) Malondialdehyde as biomarker of oxidative damage to lipids caused by smoking. Clin Chim Acta 380(1–2):50–58CrossRefPubMed Lykkesfeldt J (2007) Malondialdehyde as biomarker of oxidative damage to lipids caused by smoking. Clin Chim Acta 380(1–2):50–58CrossRefPubMed
23.
go back to reference Oberg BP, McMenamin E, Lucas FL et al (2004) Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 65(3):1009–1016CrossRefPubMed Oberg BP, McMenamin E, Lucas FL et al (2004) Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 65(3):1009–1016CrossRefPubMed
24.
go back to reference Puchades MJ, Saez G, Munos MC et al (2013) Study of oxidative stress in patients with advanced renal disease and undergoing either hemodialysis or peritoneal dialysis. Clin Nephrol 80(3):177–186CrossRefPubMed Puchades MJ, Saez G, Munos MC et al (2013) Study of oxidative stress in patients with advanced renal disease and undergoing either hemodialysis or peritoneal dialysis. Clin Nephrol 80(3):177–186CrossRefPubMed
25.
go back to reference Santangelo F, Witko-Sarsat V, Drüeke T, Descamps-Latscha B (2004) Restoring glutathione as a therapeutic strategy in chronic kidney disease. Nephrol Dial Transplant 19(8):1951–1955CrossRefPubMed Santangelo F, Witko-Sarsat V, Drüeke T, Descamps-Latscha B (2004) Restoring glutathione as a therapeutic strategy in chronic kidney disease. Nephrol Dial Transplant 19(8):1951–1955CrossRefPubMed
26.
go back to reference Ahmadpoor P, Eftekhar E, Nourooz-Zadeh J et al (2009) Glutathione, glutathione-related enzymes, and total antioxidant capacity in patients on maintenance dialysis. Iran J Kidney Dis 3(1):22–27PubMed Ahmadpoor P, Eftekhar E, Nourooz-Zadeh J et al (2009) Glutathione, glutathione-related enzymes, and total antioxidant capacity in patients on maintenance dialysis. Iran J Kidney Dis 3(1):22–27PubMed
27.
go back to reference Stępniewska J, Dołęgowska B, Popińska M et al (2014) Prooxidative-antioxidative balance of cells in different types of renal replacement therapy. Blood Purif 37(1):4–11CrossRefPubMed Stępniewska J, Dołęgowska B, Popińska M et al (2014) Prooxidative-antioxidative balance of cells in different types of renal replacement therapy. Blood Purif 37(1):4–11CrossRefPubMed
28.
go back to reference Dickinson KM, Keogh JB, Clifton PM (2009) Effects of a low-salt diet on flow-mediated dilatation in humans. Am J Clin Nutr 89(2):485–490CrossRefPubMed Dickinson KM, Keogh JB, Clifton PM (2009) Effects of a low-salt diet on flow-mediated dilatation in humans. Am J Clin Nutr 89(2):485–490CrossRefPubMed
29.
go back to reference Tzemos N, Lim PO, Wong S et al (2008) Adverse cardiovascular effects of acute salt loading in young normotensive individuals. Hypertension 51(6):1525–1530CrossRefPubMed Tzemos N, Lim PO, Wong S et al (2008) Adverse cardiovascular effects of acute salt loading in young normotensive individuals. Hypertension 51(6):1525–1530CrossRefPubMed
30.
go back to reference Fang Y, Mu JJ, He LC et al (2006) Salt loading on plasma asymmetrical dimethylarginine and the protective role of potassium supplement in normotensive salt-sensitive asians. Hypertension 48(4):724–729CrossRefPubMed Fang Y, Mu JJ, He LC et al (2006) Salt loading on plasma asymmetrical dimethylarginine and the protective role of potassium supplement in normotensive salt-sensitive asians. Hypertension 48(4):724–729CrossRefPubMed
31.
go back to reference Dunlop JL, Vandal AC, de Zoysa JR et al (2013) Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass. BMC Nephrol 14:149CrossRefPubMedPubMedCentral Dunlop JL, Vandal AC, de Zoysa JR et al (2013) Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass. BMC Nephrol 14:149CrossRefPubMedPubMedCentral
32.
go back to reference Sayarlıoglu H, Erkoc R, Tuncer M et al (2007) Effects of low sodium dialysate in chronic hemodialysis patients: an echocardiographic study. Ren Fail 29(2):143–146CrossRefPubMed Sayarlıoglu H, Erkoc R, Tuncer M et al (2007) Effects of low sodium dialysate in chronic hemodialysis patients: an echocardiographic study. Ren Fail 29(2):143–146CrossRefPubMed
33.
go back to reference Kalantar-Zadeh K, Regidor DL, Kovesdy CP et al (2009) Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation 119:671–679CrossRefPubMedPubMedCentral Kalantar-Zadeh K, Regidor DL, Kovesdy CP et al (2009) Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation 119:671–679CrossRefPubMedPubMedCentral
34.
go back to reference Capusa C, Mircescu G (2010) Oxidative stress, renal anemia, and its therapies: Is there a link? J Ren Nutr 20(5 Suppl):71–76CrossRef Capusa C, Mircescu G (2010) Oxidative stress, renal anemia, and its therapies: Is there a link? J Ren Nutr 20(5 Suppl):71–76CrossRef
Metadata
Title
Lowering dialysate sodium improves systemic oxidative stress in maintenance hemodialysis patients
Authors
Beyza Macunluoglu
Hasan Ali Gumrukcuoglu
Aydin Atakan
Halit Demir
Hamit Hakan Alp
Aytac Akyol
Serkan Akdag
Ahmet Yavuz
Zehra Eren
Sıddık Keskin
Elif Ari
Publication date
01-10-2016
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 10/2016
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-016-1367-z

Other articles of this Issue 10/2016

International Urology and Nephrology 10/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.